Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer-Reference-Cited by-同舟云学术

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

Published:2010-06-26 Issue:4 Volume:4 Page:357-368
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Muggerud Aslaug Aamodt,Hallett Michael,Johnsen Hilde,Kleivi Kristine,Zhou Wenjing,Tahmasebpoor Simin,Amini Rose-Marie,Botling Johan,Børresen-Dale Anne-Lise,Sørlie Therese,Wärnberg Fredrik

Funder

Wallenberg Consortium North and Swegene

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2010.06.007/fullpdf

Reference52 articles.

1. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution;Allred;Clin. Cancer Res,2008

2. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast;Bethwaite;J. Clin. Pathol,1998

3. Molecular characterization of human breast tumour vascular cells;Bhati;Am. J. Pathol,2008

4. Epithelial mesenchymal transition traits in human breast cancer cell lines;Blick;Clin. Exp. Metastasis,2008

5. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer;Casey;Breast Cancer Res. Treat,2009

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma;Breast Cancer Research;2024-08-13

2. The Impact of TLR9 Expression Loss on Breast Cancer Tumor Cells;2024-07-06

3. Prognostic biomarker NRG2 correlates with autophagy and epithelial‑mesenchymal transition in breast cancer;Oncology Letters;2024-04-23

4. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma;2024-03-13

5. NOTCH3 inhibits transcription factor ZEB1 expression and metastasis of breast cancer cells via transcriptionally upregulating miR-223;Journal of Cancer;2024